Last reviewed · How we verify
PD solution containing glucose
At a glance
| Generic name | PD solution containing glucose |
|---|---|
| Also known as | Dianeal (Baxter) |
| Sponsor | Iperboreal Pharma Srl |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab (PHASE1)
- Comparing Conventional Continuous Ambulatory Peritoneal Dialysis Prescription (C-CAPD) With Modified-CAPD (M-CAPD) Prescription in Children With End-stage Kidney Disease From Low-resource Settings (NA)
- Efficacy and Safety Assessments of a Peritoneal Dialysis Solution Containing Glucose, Xylitol, and L-Carnitine in CAPD (PHASE2)
- PD-HF: A Trial of Peritoneal Dialysis in Patients With Severe Heart Failure and Chronic Kidney Disease (NA)
- Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) (PHASE2)
- Study of Safety and Efficacy on New Peritoneal Dialysis Solutions (PHASE2)
- Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) (PHASE2)
- L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PD solution containing glucose CI brief — competitive landscape report
- PD solution containing glucose updates RSS · CI watch RSS
- Iperboreal Pharma Srl portfolio CI